We are a clinical stage biotechnology company developing novel immune therapeutics for the prevention, treatment and mitigation of bacterial, fungal and parasitic infections that express the antigenic target poly N-acetyl glucosamine (PNAG). That target has been found on an expanding number of pathogens. While the ultimate decision on the safety and efficacy of our therapeutics […]

We intend to focus on the entertainment and real estate sectors, including experiential entertainment. (Incorporated in the Cayman Islands) Jonathan Goldstein, the founder and CEO of Cain International, is our chairman, CEO and CFO. (Note: Cain Acquisition filed to go public in March 2021 and withdrew its SPAC IPO registration on March 7, 2022.)

We believe that we are a world leading entrepreneur Edtech and education group. Our mission is to disrupt the current education model with a student-centered, lifelong learning curriculum that prepares students with the leadership, entrepreneurial and life skills to succeed in today’s market. To help achieve our mission, we are growing from a Pre-IPO Group […]

We are a pre-clinical biopharmaceutical company developing next-generation therapeutics to improve the lives of patients suffering from inflammatory eye diseases and ocular pain. Our research program is focused on a novel G Protein-Coupled Receptor, or GPCR, which we believe plays a key role in the pathology of these inflammatory eye diseases of high unmet medical […]

Our mission is to broaden access to the multicultural education system of Canada through advanced management and technological innovation and to facilitate the achievement of a student’s full potential regardless of social or immigration status. We are a licensed provider of private online and in person educational programs and services in Canada, serving both Canadian […]

We are a clinical-stage biopharmaceutical company developing treatments for rare, chronic and serious infectious diseases with high unmet needs. Our initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease. Epetraborole has broad spectrum antimycobacterial activity through inhibition of an essential and universal step in bacterial protein synthesis. […]

In 2016, we became the holding company for Hanover Community Bank (“the Bank”), a New York-chartered community commercial bank. The bank was originally organized in 2009, with a focus on serving the South Asian community in Nassau County. After incurring financial and regulatory setbacks, the bank was recapitalized in 2012 by a group led by our […]

We intend to focus on the technology, hospitality and consumer services sectors. We will not complete our initial business combination with a target that is headquartered in China (including Hong Kong and Macau) or that conducts a majority of its business in China (including Hong Kong and Macau). (Incorporated in the Cayman Islands)  Our CEO […]

(Note: Makara Strategic Acquisition Corp. withdrew its SPAC IPO in an SEC filing dated May 15, 2023. The company filed its S-1 on Feb. 28, 2022.) We intend to focus our search for a target business in the natural resources, clean energy or energy storage sectors in the Americas, Europe or Asia. Dr. Amin Badr-El-Din is […]

We are a blank check company incorporated in the British Virgin Islands. We will primarily seek to acquire one or more growth businesses with a total enterprise value of between $300 million and $600 million. We believe that there are a substantial number of potential target businesses within this valuation range that can benefit from […]